The impact of vitamin D in breast cancer: Genomics, pathways, metabolism

Frontiers in Physiology

Volumn 5 JUN, Issue , 2014, Pages

  Narvaez, Carmen J ^a   Matthews, Donald ^a   LaPorta, Erika ^a   Simmons, Katrina M ^a   Beaudin, Sarah ^a   Welsh, JoEllen ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

1 ; Breast cancer; Calcitriol; Genomics; VDR; Vitamin D

Indexed keywords

ANTINEOPLASTIC AGENT; CALCITRIOL; CALCIUM; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR; VITAMIN D RECEPTOR AGONIST;

ANTIINFLAMMATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CELL; BREAST EPITHELIUM; CANCER GENETICS; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER TISSUE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL SPECIFICITY; DRUG MECHANISM; DRUG SCREENING; GENOMICS; HUMAN; INNATE IMMUNITY; INTERVENTION STUDY; LOW DRUG DOSE; MALIGNANT TRANSFORMATION; METABOLOMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; OBSERVATIONAL STUDY; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SIGNAL TRANSDUCTION; SUPPLEMENTATION; TUMOR MICROENVIRONMENT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN METABOLISM;

EID: 84904411997     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00213     Document Type: Article

References (106)

1. Abedin, S. A., Thorne, J. L., Battaglia, S., Maguire, O., Hornung, L. B., Doherty, A. P., et al. (2009). Elevated NCOR1 disrupts a network of dietary-sensing nuclear receptors in bladder cancer cells. Carcinogenesis 30, 449-456. doi: 10.1093/carcin/bgp005
2. Agadir, A., Lazzaro, G., Zheng, Y., Zhang, X. K., and Mehta, R. (1999). Resistance of HBL100 human breast epithelial cells to vitamin D action. Carcinogenesis 20, 577-582. doi: 10.1093/carcin/20.4.577
3. Albertson, D. G., Ylstra, B., Segraves, R., Collins, C., Dairkee, S. H., Kowbel, D., et al. (2000). Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat. Genet. 25, 144-146. doi: 10.1038/75985
4. Alvarez, J. A., Chowdhury, R., Jones, D. P., Martin, G. S., Brigham, K. L., Binongo, J. N., et al. (2014). Vitamin D status is independently associated with plasma glutathione and cysteine thiol/disulfide redox status in adults. Clin. Endocrinol. (Oxf.). doi: 10.1111/cen.12449. [Epub ahead of print].
5. Bauer, S. R., Hankinson, S. E., Bertone-Johnson, E. R., and Ding, E. L. (2013). Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies. Medicine (Baltimore) 92, 123-131. doi: 10.1097/MD.0b013e3182943bc2
6. 3 receptor in breast cancer and relation to prognosis. Cancer Res. 51, 239-244.
7. Berger, U., Wilson, P., McClelland, R. A., Colston, K., Haussler, M. R., Pike, J. W., et al. (1987). Immunocytochemical detection of 1,25-dihydroxyvitamin D3 receptor in breast cancer. Cancer Res. 47, 6793-6799.
8. Bikle, D. D. (2012). Protective actions of vitamin D in UVB induced skin cancer. Photochem. Photobiol. Sci. 11, 1808-1816. doi: 10.1039/c2pp25251a
9. Bilinski, K., and Boyages, J. (2013). Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study. Breast Cancer Res. Treat. 137, 599-607. doi: 10.1007/s10549-012-2381-1
10. Bolland, M. J., Grey, A., Gamble, G. D., and Reid, I. R. (2011). Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am. J. Clin. Nutr. 94, 1144-1149. doi: 10.3945/ajcn.111.015032
11. Bruce, D., Yu, S., Ooi, J. H., and Cantorna, M. T. (2011). Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int. Immunol. 23, 519-528. doi: 10.1093/intimm/dxr045
12. Buras, R. R., Schumaker, L. M., Davoodi, F., Brenner, R. V., Shabahang, M., Nauta, R. J., et al. (1994). Vitamin D receptors in breast cancer cells. Breast Cancer Res. Treat. 31, 191-202. doi: 10.1007/BF00666153
13. Byrne, I., Flanagan, L., Tenniswood, M., and Welsh, J. E. (2000). Identification of a hormone responsive promoter immediately upstream of exon 1c in the human vitamin D receptor gene. Endocrinology 141, 2829-2836. doi: 10.1210/en.141.8.2829
14. Caan, B. J., Sweeney, C., Habel, L. A., Kwan, M., Kroenke, C. H., Weltzien, E., et al. (2014). Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short and long term outcomes. Cancer Epidemiol. Biomarkers Prev. 23, 714-724. doi: 10.1158/1055-9965.EPI-13-1017
15. Campos, L. T., Brentani, H., Roela, R. A., Katayama, M. L., Lima, L., Rolim, C. F., et al. (2013). Differences in transcriptional effects of 1alpha,25 dihydroxyvitamin D3 on fibroblasts associated to breast carcinomas and from paired normal breast tissues. J. Steroid Biochem. Mol. Biol. 133, 12-24. doi: 10.1016/j.jsbmb.2012.08.002
16. Cancer Genome Atlas Network. (2012). Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70. doi: 10.1038/nature11412
17. Cauley, J. A., Chlebowski, R. T., Wactawski-Wende, J., Robbins, J. A., Rodabough, R. J., Chen, Z., et al. (2013). Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative. J. Womens Health (Larchmt) 22, 915-929. doi: 10.1089/jwh.2013.4270
18. Ching, S., Kashinkunti, S., Niehaus, M. D., and Zinser, G. M. (2011). Mammary adipocytes bioactivate 25-hydroxyvitamin D(3) and signal via vitamin D(3) receptor, modulating mammary epithelial cell growth. J. Cell. Biochem. 112, 3393-3405. doi: 10.1002/jcb.23273
19. Colston, K., Wilkinson, J. R., and Coombes, R. C. (1986). 1,25-Dihydroxyvitamin D3 binding in estrogen responsive rat breast tumor. Endocrinology 119, 397-403. doi: 10.1210/endo-119-1-397
20. Cordes, T., Diesing, D., Becker, S., Fischer, D., Diedrich, K., and Friedrich, M. (2007). Expression of splice variants of 1alpha-hydroxylase in MCF-7 breast cancer cells. J. Steroid Biochem. Mol. Biol. 103, 326-329. doi: 10.1016/j.jsbmb.2006.12.034
21. de Lyra, E. C., da Silva, I. A., Katayama, M. L., Brentani, M. M., Nonogaki, S., Goes, J. C., et al. (2006). 25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer. J. Steroid Biochem. Mol. Biol. 100, 184-192. doi: 10.1016/j.jsbmb.2006.04.009
22. Devitt, A., Parker, K. G., Ogden, C. A., Oldreive, C., Clay, M. F., Melville, L. A., et al. (2004). Persistence of apoptotic cells without autoimmune disease or inflammation in CD14-/- mice. J. Cell Biol. 167, 1161-1170. doi: 10.1083/jcb.200410057
23. Dogan, M., Cesur, Y., Zehra Dogan, S., Kaba, S., Bulan, K., and Cemek, M. (2012). Oxidant/antioxidant system markers and trace element levels in children with nutritional rickets. J. Pediatr. Endocrinol. Metab. 25, 1129-1139. doi: 10.1515/jpem-2012-0153
24. Edvardsen, K., Veierod, M. B., Brustad, M., Braaten, T., Engelsen, O., and Lund, E. (2011). Vitamin D-effective solar UV radiation, dietary vitamin D and breast cancer risk. Int. J. Cancer 128, 1425-1433. doi: 10.1002/ijc.25463
25. El Abdaimi, K., Dion, N., Papavasiliou, V., Cardinal, P. E., Binderup, L., Goltzman, D., et al. (2000). The vitamin D analogue EB1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells. Cancer Res. 60, 4412-4418.
26. Engel, L. S., Satagopan, J., Sima, C. S., Orlow, I., Mujumdar, U., Coble, J., et al. (2014). Sun exposure, vitamin d receptor genetic variants, and risk of breast cancer in the agricultural health study. Environ. Health Perspect. 122, 165-171. doi: 10.1289/ehp.1206274
27. Engel, P., Fagherazzi, G., Mesrine, S., Boutron-Ruault, M. C., and Clavel-Chapelon, F. (2011). Joint effects of dietary vitamin D and sun exposure on breast cancer risk: results from the French E3N cohort. Cancer Epidemiol. Biomarkers Prev. 20, 187-198. doi: 10.1158/1055-9965.EPI-10-1039
28. Escaleira, M. T., and Brentani, M. M. (1999). Vitamin D3 receptor (VDR) expression in HC-11 mammary cells: regulation by growth-modulatory agents, differentiation, and Ha-ras transformation. Breast Cancer Res. Treat. 54, 123-133. doi: 10.1023/A:1006198107805
29. Fischer, D., Seifert, M., Becker, S., Ludders, D., Cordes, T., Reichrath, J., et al. (2007). 25-Hydroxyvitamin D3 1alpha-hydroxylase splice variants in breast cell lines MCF-7 and MCF-10. Cancer Genomics Proteomics 4, 295-300.
30. Flanagan, L., Packman, K., Juba, B., O'Neill, S., Tenniswood, M., and Welsh, J. (2003). Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion. J. Steroid Biochem. Mol. Biol. 84, 181-192. doi: 10.1016/S0960-0760(03)00028-1
31. Gilad, L. A., Tirosh, O., and Schwartz, B. (2006). Phytoestrogens regulate transcription and translation of vitamin D receptor in colon cancer cells. J. Endocrinol. 191, 387-398. doi: 10.1677/joe.1.06930
32. Gordon-Thomson, C., Gupta, R., Tongkao-On, W., Ryan, A., Halliday, G. M., and Mason, R. S. (2012). 1alpha,25 dihydroxyvitamin D3 enhances cellular defences against UV-induced oxidative and other forms of DNA damage in skin. Photochem. Photobiol. Sci. 11, 1837-1847. doi: 10.1039/c2pp25202c
33. Grant, W. B. (2013). Update on evidence that support a role of solar ultraviolet-B irradiance in reducing cancer risk. Anticancer Agents Med. Chem. 13, 140-146. doi: 10.2174/187152013804487425
34. Grotsky, D. A., Gonzalez-Suarez, I., Novell, A., Neumann, M. A., Yaddanapudi, S. C., Croke, M., et al. (2013). BRCA1 loss activates cathepsin L-mediated degradation of 53BP1 in breast cancer cells. J. Cell Biol. 200, 187-202. doi: 10.1083/jcb.201204053
35. 14: a multifunctional receptor engaged in apoptosis from both sides. J. Leukoc. Biol. 65, 737-743.
36. Hopkins, M. H., Owen, J., Ahearn, T., Fedirko, V., Flanders, W. D., Jones, D. P., et al. (2011). Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial. Cancer Prev. Res. (Phila.) 4, 1645-1654. doi: 10.1158/1940-6207.CAPR-11-0105
37. Hussain, E. A., Mehta, R. R., Ray, R., Das Gupta, T. K., and Mehta, R. G. (2003). Efficacy and mechanism of action of 1alpha-hydroxy-24-ethyl-cholecalciferol (1alpha[OH]D5) in breast cancer prevention and therapy. Recent Results Cancer Res. 164, 393-411. doi: 10.1007/978-3-642-55580-0_29
38. Jacobson, E. A., James, K. A., Newmark, H. L., and Carroll, K. K. (1989). Effects of dietary fat, calcium, and vitamin D on growth and mammary tumorigenesis induced by 7,12-dimethylbenz(a)anthracene in female Sprague-Dawley rats. Cancer Res. 49, 6300-6303.
39. John, E. M., Schwartz, G. G., Dreon, D. M., and Koo, J. (1999). Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol. Biomarkers Prev. 8, 399-406.
40. John, E. M., Schwartz, G. G., Koo, J., Wang, W., and Ingles, S. A. (2007). Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am. J. Epidemiol. 166, 1409-1419. doi: 10.1093/aje/kwm259
41. Kallay, E., Bareis, P., Bajna, E., Kriwanek, S., Bonner, E., Toyokuni, S., et al. (2002). Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. Food Chem. Toxicol. 40, 1191-1196. doi: 10.1016/S0278-6915(02)00030-3
42. Kemmis, C. M., Salvador, S. M., Smith, K. M., and Welsh, J. (2006). Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3. J. Nutr. 136, 887-892.
43. Kemmis, C. M., and Welsh, J. (2008). Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway. J. Cell. Biochem. 105, 980-988. doi: 10.1002/jcb.21896
44. Kim, H. J., Lee, Y. M., Ko, B. S., Lee, J. W., Yu, J. H., Son, B. H., et al. (2011). Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer. Ann. Surg. Oncol. 18, 1830-1836. doi: 10.1245/s10434-010-1465-6
45. 3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case-control study in the multiethnic cohort study. BMC Cancer 14:29. doi: 10.1186/1471-2407-14-29
46. Knower, K. C., Chand, A. L., Eriksson, N., Takagi, K., Miki, Y., Sasano, H., et al. (2013). Distinct nuclear receptor expression in stroma adjacent to breast tumors. Breast Cancer Res. Treat. 142, 211-223. doi: 10.1007/s10549-013-2716-6
47. Krishnan, A. V., and Feldman, D. (2011). Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu. Rev. Pharmacol. Toxicol. 51, 311-336. doi: 10.1146/annurev-pharmtox-010510-100611
48. Kuhn, T., Kaaks, R., Becker, S., Eomois, P. P., Clavel-Chapelon, F., Kvaskoff, M., et al. (2013). Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study. Int. J. Cancer 133, 1689-1700. doi: 10.1002/ijc.28172
49. Laporta, E., and Welsh, J. (2013). Modeling vitamin D actions in triple-negative/basal-like breast cancer. J. Steroid Biochem. Mol. Biol. doi: 10.1016/j.jsbmb.2013.10.022. [Epub ahead of print].
50. Larriba, M. J., Bonilla, F., and Munoz, A. (2010). The transcription factors Snail1 and Snail2 repress vitamin D receptor during colon cancer progression. J. Steroid Biochem. Mol. Biol. 121, 106-109. doi: 10.1016/j.jsbmb.2010.01.014
51. Lee, H. J., Liu, H., Goodman, C., Ji, Y., Maehr, H., Uskokovic, M., et al. (2006). Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer. Biochem. Pharmacol. 72, 332-343. doi: 10.1016/j.bcp.2006.04.030
52. Lee, J. W., Paape, M. J., Elsasser, T. H., and Zhao, X. (2003). Recombinant soluble CD14 reduces severity of intramammary infection by Escherichia coli. Infect. Immun. 71, 4034-4039. doi: 10.1128/IAI.71.7.4034-4039.2003
53. Lin, J., Manson, J. E., Lee, I. M., Cook, N. R., Buring, J. E., and Zhang, S. M. (2007). Intakes of calcium and vitamin D and breast cancer risk in women. Arch. Intern. Med. 167, 1050-1059. doi: 10.1001/archinte.167.10.1050
54. Lopes, N., Paredes, J., Costa, J. L., Ylstra, B., and Schmitt, F. (2012). Vitamin D and the mammary gland: a review on its role in normal development and breast cancer. Breast Cancer Res. 14:211. doi: 10.1186/bcr3178
55. Lopes, N., Sousa, B., Martins, D., Gomes, M., Vieira, D., Veronese, L. A., et al. (2010). Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. BMC Cancer 10:483. doi: 10.1186/1471-2407-10-483
56. Maalmi, H., Ordonez-Mena, J. M., Schottker, B., and Brenner, H. (2014). Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies. Eur. J. Cancer 50, 1510-1521. doi: 10.1016/j.ejca.2014.02.006
57. Malinen, M., Saramaki, A., Ropponen, A., Degenhardt, T., Vaisanen, S., and Carlberg, C. (2008). Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and 1alpha,25-dihydroxyvitamin D3. Nucleic Acids Res. 36, 121-132. doi: 10.1093/nar/gkm913
58. McCarthy, K., Laban, C., Bustin, S. A., Ogunkolade, W., Khalaf, S., Carpenter, R., et al. (2009). Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase, and vitamin D receptor mRNA in normal and malignant breast tissue. Anticancer Res. 29, 155-157.
59. McMahon, L., Schwartz, K., Yilmaz, O., Brown, E., Ryan, L. K., and Diamond, G. (2011). Vitamin D-mediated induction of innate immunity in gingival epithelial cells. Infect. Immun. 79, 2250-2256. doi: 10.1128/IAI.00099-11
60. Mehta, R. G., Moriarty, R. M., Mehta, R. R., Penmasta, R., Lazzaro, G., Constantinou, A., et al. (1997). Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5. J. Natl. Cancer Inst. 89, 212-218. doi: 10.1093/jnci/89.3.212
61. Milani, C., Katayama, M. L., de Lyra, E. C., Welsh, J., Campos, L. T., Brentani, M. M., et al. (2013). Transcriptional effects of 1,25 dihydroxyvitamin D(3) physiological and supra-physiological concentrations in breast cancer organotypic culture. BMC Cancer 13:119. doi: 10.1186/1471-2407-13-119
62. Mittal, M. K., Myers, J. N., Misra, S., Bailey, C. K., and Chaudhuri, G. (2008). In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells. Biochem. Biophys. Res. Commun. 372, 30-34. doi: 10.1016/j.bbrc.2008.04.187
63. Mohr, S. B., Gorham, E. D., Kim, J., Hofflich, H., and Garland, C. F. (2014). Meta-analysis of Vitamin D sufficiency for improving survival of patients with breast cancer. Anticancer Res. 34, 1163-1166.
64. Nakai, K., Fujii, H., Kono, K., Goto, S., Kitazawa, R., Kitazawa, S., et al. (2014). Vitamin D activates the nrf2-keap1 antioxidant pathway and ameliorates nephropathy in diabetic rats. Am. J. Hypertens. 27, 586-595. doi: 10.1093/ajh/hpt160
65. Narvaez, C. J., Simmons, K. M., Brunton, J., Salinero, A., Chittur, S. V., and Welsh, J. E. (2013). Induction of STEAP4 correlates with 1,25-dihydroxyvitamin D3 stimulation of adipogenesis in mesenchymal progenitor cells derived from human adipose tissue. J. Cell. Physiol. 228, 2024-2036. doi: 10.1002/jcp.24371
66. Nolan, E., Donepudi, M., VanWeelden, K., Flanagan, L., and Welsh, J. E. (1998). Dissociation of vitamin D3 and anti-estrogen mediated growth regulation in MCF-7 breast cancer cells. Mol. Cell. Biochem. 188, 13-20. doi: 10.1007/978-1-4615-5763-0_2
67. Ooi, L. L., Zhou, H., Kalak, R., Zheng, Y., Conigrave, A. D., Seibel, M. J., et al. (2010). Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis. Cancer Res. 70, 1835-1844. doi: 10.1158/0008-5472.CAN-09-3194
68. Peng, X., Hawthorne, M., Vaishnav, A., St-Arnaud, R., and Mehta, R. G. (2009). 25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture. Breast Cancer Res. Treat. 113, 31-41. doi: 10.1007/s10549-008-9900-0
69. Peng, X., Vaishnav, A., Murillo, G., Alimirah, F., Torres, K. E., and Mehta, R. G. (2010). Protection against cellular stress by 25-hydroxyvitamin D3 in breast epithelial cells. J. Cell. Biochem. 110, 1324-1333. doi: 10.1002/jcb.22646
70. Peppone, L. J., Rickles, A. S., Janelsins, M. C., Insalaco, M. R., and Skinner, K. A. (2012). The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels. Ann. Surg. Oncol. 19, 2590-2599. doi: 10.1245/s10434-012-2297-3
71. Rainville, C., Khan, Y., and Tisman, G. (2009). Triple negative breast cancer patients presenting with low serum vitamin D levels: a case series. Cases J. 2:8390. doi: 10.4076/1757-1626-2-8390
72. Redaniel, M. T., Gardner, M. P., Martin, R. M., and Jeffreys, M. (2014). The association of vitamin D supplementation with the risk of cancer in postmenopausal women. Cancer Causes Control 25, 267-271. doi: 10.1007/s10552-013-0328-4
73. Rose, A. A., Elser, C., Ennis, M., and Goodwin, P. J. (2013). Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis. Breast Cancer Res. Treat. 141, 331-339. doi: 10.1007/s10549-013-2713-9
74. Rowling, M. J., Kemmis, C. M., Taffany, D. A., and Welsh, J. (2006). Megalin-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells. J. Nutr. 136, 2754-2759.
75. Santagata, S., Thakkar, A., Ergonul, A., Wang, B., Woo, T., Hu, R., et al. (2014). Taxonomy of breast cancer based on normal cell phenotype predicts outcome. J. Clin. Invest. 124, 859-870. doi: 10.1172/JCI70941
76. Scheible, C., Thill, M., Baum, S., Solomayer, E., and Friedrich, M. (2014). Implication of CYP24A1 splicing in breast cancer. Anticancer Agents Med. Chem. 14, 109-114. doi: 10.2174/18715206113139990311
77. 3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue. Breast Cancer Res. 7, R980-R986. doi: 10.1186/bcr1332
78. Simpson, E. R., and Brown, K. A. (2013). Minireview: obesity and breast cancer: a tale of inflammation and dysregulated metabolism. Mol. Endocrinol. 27, 715-725. doi: 10.1210/me.2013-1011
79. Sperati, F., Vici, P., Maugeri-Sacca, M., Stranges, S., Santesso, N., Mariani, L., et al. (2013). Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials. PLoS ONE 8:e69269. doi: 10.1371/journal.pone.0069269
80. Stein, T., Morris, J. S., Davies, C. R., Weber-Hall, S. J., Duffy, M. A., Heath, V. J., et al. (2004). Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res. 6, R75-R91. doi: 10.1186/bcr753
81. Suetani, R. J., Ho, K., Jindal, S., Manavis, J., Neilsen, P. M., Pishas, K. I., et al. (2012). A comparison of vitamin D activity in paired non-malignant and malignant human breast tissues. Mol. Cell. Endocrinol. 362, 202-210. doi: 10.1016/j.mce.2012.06.022
82. 3 suppresses COX-2 up-regulation and thromboxane production in placental trophoblast cells in response to hypoxic stimulation. Placenta 35, 143-145. doi: 10.1016/j.placenta.2013.12.002
83. Swami, S., Krishnan, A. V., Wang, J. Y., Jensen, K., Horst, R., Albertelli, M. A., et al. (2012). Dietary vitamin D(3) and 1,25-dihydroxyvitamin D(3) (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer. Endocrinology 153, 2576-2587. doi: 10.1210/en.2011-1600
84. Swami, S., Raghavachari, N., Muller, U. R., Bao, Y. P., and Feldman, D. (2003). Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res. Treat. 80, 49-62. doi: 10.1023/A:1024487118457
85. Tennant, I., Pound, J. D., Marr, L. A., Willems, J. J., Petrova, S., Ford, C. A., et al. (2013). Innate recognition of apoptotic cells: novel apoptotic cell-associated molecular patterns revealed by crossreactivity of anti-LPS antibodies. Cell Death Differ. 20, 698-708. doi: 10.1038/cdd.2012.165
86. Ting, H. J., Yasmin-Karim, S., Yan, S. J., Hsu, J. W., Lin, T. H., Zeng, W., et al. (2012). A positive feedback signaling loop between ATM and the vitamin D receptor is critical for cancer chemoprevention by vitamin D. Cancer Res. 72, 958-968. doi: 10.1158/0008-5472.CAN-11-0042
87. Townsend, K., Banwell, C. M., Guy, M., Colston, K. W., Mansi, J. L., Stewart, P. M., et al. (2005). Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin. Cancer Res. 11, 3579-3586. doi: 10.1158/1078-0432.CCR-04-2359
88. Uberti, F., Lattuada, D., Morsanuto, V., Nava, U., Bolis, G., Vacca, G., et al. (2014). Vitamin D protects Human Endothelial Cells from oxidative stress through the autophagic and survival pathways. J. Clin. Endocrinol. Metab. 99, 1367-1374. doi: 10.1210/jc.2013-2103
89. Valrance, M. E., Brunet, A. H., and Welsh, J. (2007). Vitamin D receptor-dependent inhibition of mammary tumor growth by EB1089 and ultraviolet radiation in vivo. Endocrinology 148, 4887-4894. doi: 10.1210/en.2007-0267
90. van der Rhee, H., Coebergh, J. W., and de Vries, E. (2013). Is prevention of cancer by sun exposure more than just the effect of vitamin D? A systematic review of epidemiological studies. Eur. J. Cancer 49, 1422-1436. doi: 10.1016/j.ejca.2012.11.001
91. Vidal, K., and Donnet-Hughes, A. (2008). CD14: a soluble pattern recognition receptor in milk. Adv. Exp. Med. Biol. 606, 195-216. doi: 10.1007/978-0-387-74087-4_7
92. Wall, R., Powell, A., Sohn, E., Foster-Frey, J., Bannerman, D., and Paape, M. (2009). Enhanced host immune recognition of mastitis causing Escherichia coli in CD-14 transgenic mice. Anim. Biotechnol. 20, 1-14. doi: 10.1080/10495390802594206
93. Wang, D., Velez de-la-Paz, O. I., Zhai, J. X., and Liu, D. W. (2013). Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies. Tumour Biol. 34, 3509-3517. doi: 10.1007/s13277-013-0929-2
94. Warburg, O. (1956). On the origin of cancer cells. Science 123, 309-314. doi: 10.1126/science.123.3191.309
95. Welsh, J. (2012). Cellular and molecular effects of vitamin D on carcinogenesis. Arch. Biochem. Biophys. 523, 107-114. doi: 10.1016/j.abb.2011.10.019
96. Welsh, J., Zinser, L. N., Mianecki-Morton, L., Martin, J., Waltz, S. E., James, H., et al. (2011). Age-related changes in the epithelial and stromal compartments of the mammary gland in normocalcemic mice lacking the vitamin D3 receptor. PLoS ONE 6:e16479. doi: 10.1371/journal.pone.0016479
97. Wietzke, J. A., and Welsh, J. (2003). Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells. J. Steroid Biochem. Mol. Biol. 84, 149-157. doi: 10.1016/S0960-0760(03)00024-4
98. Willnow, T. E., and Nykjaer, A. (2002). Pathways for kidney-specific uptake of the steroid hormone 25-hydroxyvitamin D3. Curr. Opin. Lipidol. 13, 255-260. doi: 10.1097/00041433-200206000-00004
99. Yao, S., and Ambrosone, C. B. (2013). Associations between vitamin D deficiency and risk of aggressive breast cancer in African-American women. J. Steroid Biochem. Mol. Biol. 136, 337-341. doi: 10.1016/j.jsbmb.2012.09.010
100. Zheng, J., Watson, A. D., and Kerr, D. E. (2006). Genome-wide expression analysis of lipopolysaccharide-induced mastitis in a mouse model. Infect. Immun. 74, 1907-1915. doi: 10.1128/IAI.74.3.1907-1915.2006
101. Zheng, W., Tayyari, F., Gowda, G. A., Raftery, D., McLamore, E. S., Shi, J., et al. (2013). 1,25-dihydroxyvitamin D regulation of glucose metabolism in Harvey-ras transformed MCF10A human breast epithelial cells. J. Steroid Biochem. Mol. Biol. 138, 81-89. doi: 10.1016/j.jsbmb.2013.03.012
102. Zhong, W., Gu, B., Gu, Y., Groome, L. J., Sun, J., and Wang, Y. (2014). Activation of vitamin D receptor promotes VEGF and CuZn-SOD expression in endothelial cells. J. Steroid Biochem. Mol. Biol. 140, 56-62. doi: 10.1016/j.jsbmb.2013.11.017
103. Zinser, G., Packman, K., and Welsh, J. (2002). Vitamin D(3) receptor ablation alters mammary gland morphogenesis. Development 129, 3067-3076.
104. Zinser, G. M., McEleney, K., and Welsh, J. (2003). Characterization of mammary tumor cell lines from wild type and vitamin D(3) receptor knockout mice. Mol. Cell. Endocrinol. 200, 67-80. doi: 10.1016/S0303-7207(02)00416-1
105. 3 receptor null mice. Mol. Endocrinol. 18, 2208-2223. doi: 10.1210/me.2003-0469
106. Zinser, G. M., and Welsh, J. (2004b). Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Carcinogenesis 25, 2361-2372. doi: 10.1093/carcin/bgh271